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OBJECTIVE: After acute myocardial infarction, during the cardiac repair phase, periostin is released into the
infarct and activates signaling pathways that are essential for the reparative process. However, the role of
periostin in chronic cardiac remodeling after myocardial infarction remains to be elucidated. Therefore, the
objective of this study was to investigate the relationship between tissue periostin and cardiac variables in the
chronic cardiac remodeling induced by myocardial infarction.
METHODS: Male Wistar rats were assigned to 2 groups: a simulated surgery group (SHAM; n=8) and a
myocardial infarction group (myocardial infarction; n = 13). After 3 months, morphological, functional and
biochemical analyses were performed. The data are expressed as means¡SD or medians (including the lower
and upper quartiles).
RESULTS: Myocardial infarctions induced increased left ventricular diastolic and systolic areas associated with a
decreased fractional area change and a posterior wall shortening velocity. With regard to the extracellular
matrix variables, the myocardial infarction group presented with higher values of periostin and types I and III
collagen and higher interstitial collagen volume fractions and myocardial hydroxyproline concentrations. In
addition, periostin was positively correlated with type III collagen levels (r = 0.673, p= 0.029) and diastolic
(r = 0.678, p= 0.036) and systolic (r = 0.795, p= 0.006) left ventricular areas. Considering the relationship
between periostin and the cardiac function variables, periostin was inversely correlated with both the fractional
area change (r = -0.783, p= 0.008) and the posterior wall shortening velocity (r = -0.767, p= 0.012).
CONCLUSIONS: Periostin might be a modulator of deleterious cardiac remodeling in the chronic phase after
myocardial infarction in rats.
KEYWORDS: Fibrosis; Myocardial Infarction; Periostin.
Minicucci MF, Santos PP, Rafacho BP, Gonc¸alves AF, Ardisson LP, Batista DF, et al. Periostin as a modulator of chronic cardiac remodeling after
myocardial infarction. Clinics. 2013;68(10):1344-1349.
Received for publication on March 26, 2013; First review completed on April 28, 2013; Accepted for publication on May 16, 2013
E-mail: lzornoff@fmb.unesp.br
Tel.: 55 14 3822-2969
& INTRODUCTION
Cardiac remodeling describes changes in the size,
geometry, shape, composition and function of the heart
after cardiac injury. Importantly, chronic ventricular remo-
deling is now recognized as an important pathological
process that results in progressive ventricular dysfunction
and the clinical presentation of heart failure or death (1-4).
Thus, it is critical to know the pathophysiological alterations
involved in these processes.
After myocardial infarction (MI), remodeling is a
dynamic process that results from the activation of
molecular and cellular pathways involving both myocytes
and extracellular matrix components, including collagens,
glycoproteins, proteoglycans, glycosaminoglycans and
matricellular proteins (5,6).
Matricellular proteins are a family of structurally unre-
lated extracellular macromolecules that play limited roles in
tissue architecture but serve as links between cells and the
extracellular matrix. In general, matricellular proteins are
minimally expressed in normal hearts but are upregulated
following cardiac injury (7).
One of the most important matricellular proteins is
periostin, which plays a role in the maturation and
differentiation of fibroblasts in the developing neonatal
heart (7). After acute MI, during the cardiac repair phase,
periostin is released into the infarct and activates signaling
pathways that are essential for the reparative process (8-11).
However, the role of periostin in chronic cardiac remodeling
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after MI remains to be elucidated. Therefore, the objective of
this study was to investigate the relationship between
periostin and cardiac variables in the chronic cardiac
remodeling induced by coronary occlusion in rats.
& MATERIALS AND METHODS
All experiments and procedures were performed in
accordance with the National Institute of Health’s Guide
for the Care and Use of Laboratory Animals and were
approved by the Animal Ethics Committee of our institu-
tion.
Male Wistar rats that weighed 200-250 g were assigned to
2 groups. One group underwent simulated surgery without
the induction of an MI (SHAM group; n = 8), and the other
group was subjected to an MI (MI group; n = 13). Water and
diet were supplied ad libitum. The rats were observed for 3
months, after which morphological, functional and bio-
chemical analyses were performed.
Coronary artery ligation
When the animals achieved body weights of 200-250 g, an
MI was induced as previously described (12,13). In brief, the
rats were anesthetized with ketamine (70 mg/kg) and
xylazine (1 mg/kg), and after a left thoracotomy, the heart
was exteriorized. The left atrium was retracted to facilitate
the ligation of the left coronary artery with 5-0 mononylon
between the pulmonary outflow tract and the left atrium.
The heart was then replaced in the thorax, and the lungs
were inflated by positive pressure as the thoracotomy was
closed. The rats were housed in a temperature-controlled
room (24 C˚) with a 12-h light:dark cycle.
Echocardiographic analysis
After 3 months, all animals were weighed and evaluated
by a transthoracic echocardiographic exam (14,15). The
same observer made all measurements according to the
leading-edge method recommended by the American
Society of Echocardiography/European Association of
Echocardiography (16). The end-systolic and end-diastolic
cavity areas were calculated as the sum of the areas from
both the short- and long-axis views in diastole (SumD) and
systole (SumS), respectively. The fractional area change
(FAC) was calculated from the composite cavity areas as
follows: FAC = (SumD-SumS)/SumD. Additionally, the left
ventricular mass index (LVMI) was calculated using the
equation LVMI = {[(LVEDD+2*LVWT)3–(LVEDD)3 ]*1.04}/
BW. The transmitral diastolic flow velocities (E and A
velocities) were obtained from the apical four-chamber
view. The E/A ratio, the isovolumetric relaxation time and
the isovolumetric relaxation time corrected by the heart rate
(TRIV/RR0.5) were used as indices of the left ventricular
(LV) diastolic function.
In vitro left ventricular function analysis
One day after the echocardiographic study, the rats were
anesthetized with thiopental sodium (50 mg/kg, i.p.) and
were administered heparin (2000 UI, i.p.). The chest was
subjected to a median sternotomy under artificial ventila-
tion. The entire heart was quickly removed from the chest
and transferred to a perfusion apparatus (model 830 Hugo
Sachs Eletronick-Green-stasse). The ascending aorta was
isolated and cannulated for retrograde perfusion with
filtered and oxygenated Krebs-Henseleit solution, which
was maintained at a constant temperature (37 C˚) and
perfusion pressure (75 mmHg). All hearts were paced at
200 to 250 beats/min. The procedures and measurements
were performed following a previously described method
(17).
Morphometric analysis
Upon the completion of the functional analyses, the
right and left ventricles (including the interventricular
septum) were dissected, separated and weighed.
Transverse sections of the LV were fixed in 10% buffered
formalin and embedded in paraffin. Five-micron-thick
sections were stained with hematoxylin and eosin (HE) or
the collagen-specific stain picrosirius red (Sirius red F3BA
in aqueous saturated picric acid). The myocyte cross-
sectional area was determined for a minimum of 100
myocytes per HE-stained cross-section. Measurements
were obtained from digital images (4006 magnification)
that were collected with a video camera attached to a Leica
microscope; the images were analyzed with the Image-Pro
Plus 3.0 software program (Media Cybernetics; Silver
Spring, MD). The myocyte cross-sectional area was
measured with a digital pad, and the selected cells were
transversely cut in such a way that the nucleus was in the
center of the myocyte (18). The interstitial collagen volume
fraction was determined for the entire cardiac section that
was stained with picrosirius red by analyzing digital
images that were captured under polarized light (2006
magnification). The cardiac tissue components were
identified according to the following staining patterns:
red for collagen fibers, yellow for myocytes and white for
interstitial space. The collagen volume fraction was
calculated as the sum of all of the connective tissue areas
divided by the sum of all of the connective tissue and
myocyte areas. On average, 35 microscopic fields per heart
were analyzed with a 206 lens. Perivascular collagen was
excluded from this analysis (19). The infarcted and viable
muscle lengths for both the endocardial and epicardial
circumferences were determined using planimetry. The
infarct size was calculated by dividing the endocardial and
epicardial circumferences of the infarcted area by the total
epicardial and endocardial ventricular circumferences. The
measurements on the midventricular slices (5-6 mm from
the apex) were performed under the assumption that the
left midventricular slice had a close linear relationship
with the sum of the area measurements from all of the
heart slices (20).
Myocardial hydroxyproline concentration
The myocardial hydroxyproline concentration was used
to estimate the extent of fibrosis. Hydroxyproline (HOP)
was measured in the tissues (the septum of the LV and the
mid-ventricular slice of the RV) according to the method
described previously (21). Briefly, the tissues were dried for
4 h using a Speedvac Concentrator SC 100 that was attached
to a refrigerated condensation trap (RVT 100) and vacuum
pump (VP 100, Savant Instruments, Inc., Farmingdale, NY).
The dry weights of the tissues were determined, and the
samples were hydrolyzed overnight at 110 C˚ with 6 N HCl
(1 ml/10 mg dry tissue). A 50-ml aliquot of the hydrolysate
was transferred to an Eppendorf tube and dried in the
Speedvac Concentrator. Deionized water (1 ml) was added,
and the sample was transferred to a tube with a Teflon
screw cap. Potassium borate buffer (1 ml, pH 8.7) was
CLINICS 2013;68(10):1344-1349 Periostin post-infarction
Minicucci MF et al.
1345
added to maintain a constant pH, and the sample was
oxidized with 0.3 ml of chloramine T solution at room
temperature for exactly 20 min. The oxidative process was
stopped by adding 1 ml of 3.6 mol/l sodium thiosulfate and
mixing thoroughly for 10 s. The solution was saturated with
1.5 g of KCl. The tubes were capped and heated in boiling
water for 20 min. After cooling to room temperature, the
aqueous layer was extracted with 2.5 ml of toluene. Next,
1 ml of toluene extract was transferred to a 12675 mm test
tube. Then, 0.4 ml of Ehrlich’s reagent was added to allow
the color to develop for 30 min. The absorbances were read
at 565 nm against a reagent blank. Deionized water and
20 mg/ml HOP were used as the blank and standard,
respectively (22).
Western blot analysis
LV samples were extracted using Tris-Triton buffer
(10 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5%
deoxycholate, 1 nM EDTA, 1 mM EGTA, a 1 mM mixture of
protease inhibitors, 1 mM sodium orthovanadate, 1 mM
sodium fluoride and 1% leupeptin, aprotinin and pepstatin)
to detect collagen I, collagen III and periostin. The samples
were then centrifuged at 12,000 rpm at 4 C˚ for 20 min, and
the supernatant was collected. The supernatant protein
content was quantified using the Bradford method. The
samples were separated on a 10% SDS-polyacrylamide gel,
and the separated proteins were transferred to a nitrocellu-
lose membrane. The membrane was blocked with 5% nonfat
dry milk in Tris-buffered saline containing Tris 1 M pH 8.0,
NaCl 5 M and Tween-20 at room temperature for 2 h. The
membrane was then incubated with the following primary
antibodies: anti-collagen III, mouse monoclonal IgG1
(Abcam, Inc., Canada, ab 6310); anti-collagen I A1, rabbit
polyclonal IgG (Santa Cruz Biotechnology, Inc., Europe, sc
8784R); and anti-periostin, goat polyclonal IgG (Santa Cruz
Biotechnology, Inc., Europe, sc 49480). The membrane was
washed with TBS and Tween-20 and was then incubated
with secondary peroxidase-conjugated antibodies. A Super
SignalH West Pico Chemiluminescent Substrate (Pierce
Protein Research Products, Rockford, USA) was used to
detect the bound antibodies. GAPDH (GAPDH [6C5],
mouse monoclonal IgG1, Santa Cruz Biotechnology, Inc.,
Europe, sc 32233) was used for western blot normalization
of collagen I, III and periostin.
Statistical analysis
The data are expressed as means¡SD or medians (includ-
ing the lower and upper quartiles). The Kolmogorov-Smirnov
test was used to test for the normally distributed data.
Comparisons between groups were performed using
Student’s t test for parameters with normal distributions.
Otherwise, comparisons between groups were performed
using the Mann-Whitney U test. Correlations between
continuous variables were performed with the Spearman’s
test. The x2 test or Fisher Exact test was used to compare
categorical variables. The data analyses were performed with
SigmaStat for Windows v2.03 (SPSS Inc., Chicago, IL). The
significance level was set at 5%.
& RESULTS
The mean infarct size was 33.2¡13.4%, and the rats in the
SHAM group weighed more 3 months after surgery. The
echocardiographic data are listed in Table 1. The animals in
the MI group had higher values of left cardiac chambers
corrected by body weight, higher LVMIs and lower relative
wall thicknesses (RWTs) compared with the SHAM group.
In addition, there were no differences in the diastolic
function variables; however, systolic function was worse in
the MI group.
The in vitro LV function data revealed worse systolic (+
dP/dt max: SHAM: 4375¡843, MI: 2675¡813 mmHg/s;
p = 0.012) and diastolic functions (- dP/dt max: SHAM: 2125
[1969-2500], MI: 1750.0 [1219-1750] mmHg/s; p= 0.008) in
the MI group (Table 2).
The morphological data are listed in Table 3. The BW-
corrected right ventricular weight (RVW) was elevated in the
MI group. This result, which suggests cardiac hypertrophy,
was in agreement with the higher values of the myocyte
cross-sectional area (MCA) (SHAM: 305.7¡53.1, MI:
492.6¡65.3 mm2; p,0.001) observed in the MI group. In
addition, the interstitial collagen volume fraction (SHAM:
1.85¡0.70, MI: 4.02¡0.61%; p,0.001) and HOP concentration
Table 1 - Echocardiographic data.
SHAM (n=8) Myocardial infarction (n= 13) p-value
BW, (g) 490¡29 459¡32 0.037
HR, (bpm) 293 (280-307) 315 (290-340) 0.147
LVWT, (mm) 1.40 (1.38-1.46) 1.49 (1.45-1.74) 0.063
LVEDD/BW (mm/kg) 16.6 (16.0-17.9) 23.1 (21.5-26.1) ,0.001
LVESD/BW (mm/kg) 7.58 (6.99-8.43) 16.6 (15.3-20.6) ,0.001
LA/BW, (mm/kg) 12.2 (11.8-13.2) 15.5 (13.6-18.5) 0.003
RWT 0.34¡0.02 0.29¡0.03 ,0.001
Mitral E wave, (cm/s) 75.5 (71.5-79.5) 99.0 (75.5-118.3) 0.096
Mitral A wave, (cm/s) 51.0 (48.0-61.0) 57.0 (13.8-61.0) 0.799
Mitral E/A 1.51 (1.34-1.56) 1.78 (1.28-9.11) 0.405
IVRT/RR0.5, (ms) 54.7 (35.6-58.6) 47.9 (44.6-49.1) 0.885
EDT, (ms) 38.8¡6.69 33.9¡6.01 0.094
PWSV, (mm/s) 36.4¡4.0 27.7¡3.9 ,0.001
FAC, (%) 75.3¡7.25 36.1¡7.80 ,0.001
SHAM: rats subjected to surgery but without coronary occlusion; BW: body weight; HR: heart rate; LVWT: LV posterior wall thickness; LVEDD: LV end-
diastolic dimension; LVESD: LV end-systolic dimension; LA: left atrium; RWT: relative wall thickness; E wave: peak velocity of transmitral flow during early
ventricular filling; A wave: peak velocity of transmitral flow during atrial contraction; IVRT/RR0.5: isovolumetric relaxation time corrected for heart rate;
EDT: E wave deceleration time; PWSV: posterior wall shortening velocity; FAC: fractional area change. Data are expressed as means¡SD or medians (25%-
75%).
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(SHAM: 3.32¡0.75, MI: 5.48¡0.73 mg/mg; p= 0.002) were
higher in the MI group.
Periostin (SHAM: 0.0009 [0.0007-0.0015], MI: 0.156 [0.111-
0.234); p= 0.016] and collagen types I (SHAM: 1.90¡1.07,
MI: 4.14¡0.82; p = 0.009) and III (SHAM: 1.01 [0.91-1.13], MI:
9.26 [6.61-10.73]; p= 0.016) were higher in the MI group than
in the SHAM group (Table 4).
The periostin level was positively correlated with the type
III collagen level (r = 0.673, p = 0.029) but not with the type I
collagen level (r = 0.370, p= 0.275). Taking into account the
relationship between periostin and the cardiac function
variables, periostin was inversely correlated with FAC
(r = -0.783, p= 0.008) and PWSV (r = -0.767, p = 0.012).
Considering the association between periostin and the
morphological variables, periostin was positively correlated
with both the diastolic (r = 0.678, p = 0.036) and systolic
(r = 0.795, p= 0.006) LV areas.
& DISCUSSION
The objective of this study was to analyze the contribution
of periostin in the chronic cardiac remodeling induced by
MI. The expression of cardiac periostin increased 3 months
after infarction. In addition, there were strong associations
among periostin and cardiac fibrosis, ventricular enlarge-
ment and cardiac systolic dysfunction. Therefore, our data
suggest that periostin might play a pathophysiological role
in the detrimental chronic remodeling process following
coronary occlusion in rats.
Extracellular matrix components play a critical role in the
cardiac remodeling process. The most dramatic changes in
the cardiac extracellular matrix occur in the scenario of
acute MI. Indeed, in the early period, abundant inflamma-
tory leukocytes infiltrate the infarcted area and phagocytose
dead cells and matrix debris. Then, the regression of
inflammatory signals is noted, and fibroblasts produce
large amounts of extracellular matrix proteins, including
collagen types I and III. Finally, a mature scar is formed.
Thus, alterations in the inflammatory, proliferative and
maturation phases may result in fatal complications after
MI. For instance, slower healing, which results in an
infarcted area more susceptible to deformations, might
provoke infarct expansion, aneurysm formation, arrhythmia
and cardiac rupture after infarction (1,4). Importantly, the
composition of the extracellular matrix plays a key role
during all of the phases of infarct healing (7).
It is accepted that periostin is a critical modulator of
collagen deposition, fibrosis and scar mechanics (23).
Periostin expression by cardiac fibroblasts is high during
early neonatal life and subsequently declines to barely
detectable levels in adult life (24). However, periostin is
upregulated in the injured heart and plays a critical role in
the regulation of inflammatory, reparative and fibrotic
pathways (24). Thus, knowledge of the effects of periostin
on cardiac remodeling after MI is pivotal.
The role of periostin during the infarct-healing phase has
been studied. In mice, immunohistochemical analysis 1
week after MI revealed a massive accumulation of periostin
within the scar. In addition, periostin-null mice had
significantly increased mortality during the first 10 days
after MI, which was associated with a 2-fold greater rate of
ventricular rupture compared with the controls (11).
Another study on periostin-null mice found that, after acute
MI, cardiac healing was impaired, resulting in a cardiac
rupture as a consequence of reduced myocardial stiffness
caused by impaired collagen formation (10). Therefore, the
data strongly suggest that periostin is essential for cardiac
healing after acute MI by promoting myofibroblast migra-
tion and activation.
In contrast to the function of periostin during the infarct-
healing phase, the role of periostin during the chronic phase
following an MI is less clear. Indeed, as mentioned
previously, shortly after coronary occlusion, periostin-null
mice presented with greater ventricular ruptures. However,
periostin-null mice surviving the acute phase had signifi-
cantly reduced fibrosis in the non-infarcted area, which was
associated with the attenuation of the ventricular systolic
Table 2 - In vitro left ventricular function data.
Variables SHAM (n=5) Myocardial infarction (n= 5) p-value
+ dP/dt max, (mmHg/s) 4375¡843 2675¡813.0 0.012
- dP/dt max, (mmHg/s) 2125 (1969-2500) 1750.0 (1219-1750) 0.008
SHAM: rats subjected to surgery but without coronary occlusion; +dP/dt max: maximum rate of ventricular pressure rise; -dP/dt max: maximum rate of
ventricular pressure decrease. Data are expressed as means¡SD or medians (25%-75%).
Table 3 - Morphometric data and myocardial hydroxyproline concentration.
SHAM (n=8) Myocardial infarction (n= 13) p-value
LVW/BW, (g/kg) 1.76¡0.17 2.11¡0.57 0.110
RVW/BW, (g/kg) 0.39 (0.36-0.43) 0.54 (0.47-1.04) ,0.001
Lung WC, (%) 76.2 (72.1-77.3) 75.4 (73.5-77.2) 0.913
Liver WC, (%) 68.4 (66.1-69.0) 67.7 (67.4-68.0) 0.205
IC*, (%) 1.85¡0.70 4.02¡0.61 ,0.001
CSA*, (mm2) 306¡53 493¡65 ,0.001
HOP**, (mg/mg) 3.32¡0.75 5.48¡0.73 0.002
*7 rats per group; ** 5 rats per group. SHAM: rats subjected to surgery but without coronary occlusion; BW: body weight; LVW: left ventricular weight;
RVW: right ventricular weight; WC: water content; IC: interstitial collagen volume fraction; CSA: myocyte cross-sectional area; HOP: hydroxyproline. Data
are expressed as means¡SD or medians (25%-75%).
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dysfunction 8 weeks after the infarct (11). In another study,
Kuhn et al. administered Gelfoam patches loaded with
periostin in rats subjected to coronary occlusion. Between 1
and 12 weeks, the shortening and ejection fractions in
coronary occlusion rats increased significantly in compar-
ison to the control animals. In addition, at 1 week after MI,
the treatment and control groups had the same LV
dimensions. However, at 12 weeks, the end-diastolic
dimension was smaller in the periostin-treated rats, sug-
gesting improved ventricular remodeling in those rats (9).
Therefore, considering the conflicting results, the role of
periostin in chronic cardiac remodeling after MI remains to
be elucidated.
In our study, the infarcted rats presented with increased
LV dimensions. LV enlargement can occur soon after MI as
a result of infarct expansion, which increases the surface of
the infarcted area by the stretching and thinning of the
damaged region. As a result of post-infarction expansion,
parietal tension is significantly increased, inducing the
process of eccentric hypertrophy. Therefore, regardless of
its complexity, after myocardial infarction, the remodeling
process is frequently used as a synonym for ventricular
dilation (1-4). Consequently, our data indicated that
myocardial infarction induced remodeling. It is well
accepted that collagen accumulation in non-infarcted areas
is a crucial component of remodeling (5,6). In accordance
with this concept, LV dilation was associated with fibrosis
and was accessed using biochemical, histological and
molecular methods. Importantly, we found a correlation
among periostin and collagen variables, indicating that
periostin might also be a relevant determinant of cardiac
fibrosis in the chronic phase after MI.
Although the relationship between periostin and collagen
is indisputable, the association between periostin and
hypertrophy is less apparent. In a model of pressure
overload, periostin-null mice experienced decreased hyper-
trophy after 8 weeks compared with the control mice (11).
However, in another study, periostin did not induce
hypertrophy of differentiated cardiomyocytes (9). In our
study, there was a strong correlation between the periostin
level and the LV dimension associated with an inverse
correlation between periostin and cardiac systolic function,
suggesting that periostin can modulate the chronic remo-
deling process after MI.
In conclusion, our results suggest that periostin might be a
modulator of deleterious cardiac remodeling in the chronic
phase after MI in rats.
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